Scientists call for more drugs, vaccines for multidrug-resistant TB

05/18/2010 | Reuters

Spending on research and development of drugs and vaccines for multidrug-resistant strains of tuberculosis should be increased as MDR-TB starts to advance in some countries, scientists said. Additional vaccines, treatments and diagnostic tests could reduce the global incidence of TB by 94% by 2050, they said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC